BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Cullinan Therapeutics (NASDAQ:CGEM)

1 post

Biotech NewsCullinan Therapeutics (CGEM) Could Be the Biotech Stock the Market Mispriced

  • BioTech Health X
  • January 23, 2026
Built on the idea that meaningful breakthroughs in medicine come from bold science paired with disciplined execution, this…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • This Biotech Is Burning Cash Faster Than Its Market Value — SCYNEXIS (SCYX)
  • Lexicon Pharmaceuticals (LXRX) Proves That Boring Science Can Still Move Markets
  • Here’s Why Avidity Biosciences (RNA) Keeps Hitting New Highs Despite Being Unprofitable
  • Exelixis (EXEL) Isn’t a Flashy Biotech — It’s the One Quietly Making Billions
  • Nearly 99% Institutional Ownership — Why Big Money Won’t Let Go of Bio-Techne (TECH)
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 23, 2026
    This Biotech Is Burning Cash Faster Than Its Market Value — SCYNEXIS (SCYX)
    • January 23, 2026
    Lexicon Pharmaceuticals (LXRX) Proves That Boring Science Can Still Move Markets
    • January 23, 2026
    Here’s Why Avidity Biosciences (RNA) Keeps Hitting New Highs Despite Being Unprofitable
    • January 23, 2026
    Exelixis (EXEL) Isn’t a Flashy Biotech — It’s the One Quietly Making Billions
    • January 23, 2026
    Nearly 99% Institutional Ownership — Why Big Money Won’t Let Go of Bio-Techne (TECH)
Recent Posts
  • Why Madrigal Pharma (MDGL) Looks Like an “Overnight Success” — After Years of Relentless Science
    • January 23, 2026
  • Harmony Biosciences (HRMY) Keeps Beating Expectations While Biotech Struggles
    • January 23, 2026
  • 23% of Traders Are Short This Oncology Stock — Here’s What They Might Be Missing About ORIC Pharma (ORIC)
    • January 23, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (731)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top